ALNYLAM PHARMACEUTICALS, INC.: capex

Value{"amount": 140156000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2019-01-01 – 2019-12-31
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-20-000004
Retrieved: 2026-08-19T11:51:50.761763+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/capex/2019-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/748dbaa7-48cb-403d-b79a-16659b898894

History